Organoids: An intermediate modeling platform in precision oncology

MZ Jin, RR Han, GZ Qiu, XC Ju, G Lou, WL Jin - Cancer letters, 2018 - Elsevier
Cancer harbors variable heterogeneity and plasticity. Thus far, our comprehension is greatly
based on cell lines, organoids, and patient-derived tumor xenografts (PDTXs). Organoids …
被引用次数：75 相关文章

Organoids: An intermediate modeling platform in precision oncology

MZ Jin, RR Han, GZ Qiu, XC Ju, G Lou… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Cancer harbors variable heterogeneity and plasticity. Thus far, our comprehension is greatly
based on cell lines, organoids, and patient-derived tumor xenografts (PDTXs). Organoids …

[引用][C] Organoids: An intermediate modeling platform in precision oncology

MZ Jin, RR Han, GZ Qiu, XC Ju, G Lou, WL Jin - Cancer Letters, 2018 - cir.nii.ac.jp
Organoids: An intermediate modeling platform in precision oncology | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Organoids: An intermediate modeling platform in precision oncology.

MZ Jin, RR Han, GZ Qiu, XC Ju, G Lou, WL Jin - Cancer Letters, 2017 - europepmc.org
Cancer harbors variable heterogeneity and plasticity. Thus far, our comprehension is greatly
based on cell lines, organoids, and patient-derived tumor xenografts (PDTXs). Organoids …